Neurocrine Biosciences Inc vs SMX Security Matters plc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while SMX Security Matters plc trades at $19.04 (market cap $16.38M). The key difference: Neurocrine Biosciences Inc is far larger — about 1062.3× SMX Security Matters plc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals.
| NBIX | SMX | |
|---|---|---|
Market Cap | $17.40B | $16.38M |
Sector | Health | Technology |
52-Week High | $180.55 | $295.56K |
52-Week Low | $123.10 | $12.87 |
Enterprise Value | $16.49B | $13.35M |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →